Daniel J. Curran insider trades

Open-market stock purchases and sales by Daniel J. Curran, Director at Catalyst Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 14, 2024.

Recent trades

DateStockTradeValue
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jun 11, 2026XLO Xilio Therapeutics, IncBought (not open market)—
Jan 20, 2026ALXO ALX Oncology Holdings IncBought (not open market)—
Nov 20, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 20, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—

Companies traded

  • CPRX Catalyst Pharmaceuticals, Inc: other filings, last Jul 15, 2026
  • XLO Xilio Therapeutics, Inc: other filings, last Jun 11, 2026
  • ALXO ALX Oncology Holdings Inc: other filings, last Jan 20, 2026

Get free alerts when Daniel J. Curran files a new trade →